Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Functional outcome improvement and surgical time reduction in a single-surgeon consecutive case series of hip arthroscopy for femoroacetabular impingement: A minimum 5 years follow-up study.
Tassinari E, Caternicchia F, Rosa MD, Castagnini F, Angeletti E, Fantoni V, Tampieri I, Burla A, Zaffagnini S. Tassinari E, et al. J Exp Orthop. 2025 Jan 22;12(1):e70022. doi: 10.1002/jeo2.70022. eCollection 2025 Jan. J Exp Orthop. 2025. PMID: 39845699 Free PMC article.
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer.
Guardigni M, Greco G, Poeta E, Santini A, Tassinari E, Bergamini C, Zalambani C, De Simone A, Andrisano V, Uliassi E, Monti B, Bolognesi ML, Fimognari C, Milelli A. Guardigni M, et al. Among authors: tassinari e. RSC Med Chem. 2024 May 2;15(6):2045-2062. doi: 10.1039/d4md00175c. eCollection 2024 Jun 19. RSC Med Chem. 2024. PMID: 38911150 Free PMC article.
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer's Disease.
Santini A, Tassinari E, Poeta E, Loi M, Ciani E, Trazzi S, Piccarducci R, Daniele S, Martini C, Pagliarani B, Tarozzi A, Bersani M, Spyrakis F, Danková D, Olsen CA, Soldati R, Tumiatti V, Montanari S, De Simone A, Milelli A. Santini A, et al. Among authors: tassinari e. ACS Chem Neurosci. 2024 Jun 5;15(11):2099-2111. doi: 10.1021/acschemneuro.4c00061. Epub 2024 May 15. ACS Chem Neurosci. 2024. PMID: 38747979
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience.
Mollica V, Marchetti A, Fraccascia N, Nanni C, Tabacchi E, Malizia C, Argalia G, Rosellini M, Tassinari E, Paccapelo A, Fanti S, Massari F. Mollica V, et al. Among authors: tassinari e. ESMO Open. 2024 May;9(5):103448. doi: 10.1016/j.esmoop.2024.103448. Epub 2024 May 7. ESMO Open. 2024. PMID: 38718704 Free PMC article. Clinical Trial.
64 results